Ranbaxy USA Inc.

GPTKB entity

Properties (61)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition Acquired_by_Sun_Pharmaceutical_Industries_in_2014
gptkbp:awards Various industry awards
gptkbp:CEO Abhay_Gandhi
gptkbp:certifications ISO_certified
gptkbp:challenges Technological advancements
Intellectual property issues
Supply chain disruptions
Consumer preferences
Market competition
Regulatory challenges
Quality control issues
Global economic conditions
Product recalls
Supply chain issues
Labor issues
Healthcare reforms
Changing regulations
Public perception issues
Technological disruptions
Currency fluctuations
Pricing pressures
Market access barriers
Emerging market dynamics
Patent litigations
Trade_policies
Healthcare_costs
gptkbp:clinicalTrials Conducts clinical trials
gptkbp:communityEngagement Health awareness campaigns
gptkbp:employees Approximately 1,000
gptkbp:focus Research and development
gptkbp:founded 1994
gptkbp:headquarters gptkb:Princeton,_New_Jersey
https://www.w3.org/2000/01/rdf-schema#label Ranbaxy USA Inc.
gptkbp:industry Pharmaceuticals
gptkbp:keyPeople gptkb:Dilip_Shanghvi
gptkbp:location gptkb:North_America
gptkbp:market gptkb:United_States
gptkbp:parentCompany gptkb:Sun_Pharmaceutical_Industries
gptkbp:partnerships Various healthcare organizations
gptkbp:productLine Antibiotics
Vaccines
Oncology drugs
Dermatology products
Nutraceuticals
Cardiovascular drugs
Diabetes medications
Pain management drugs
CNS drugs
Gastrointestinal drugs
Respiratory drugs
Hormonal drugs
gptkbp:products Generic_drugs
gptkbp:regulatoryCompliance FDA_approved_products
gptkbp:researchInterest Multiple_locations_in_the_USA
gptkbp:revenue $1 billion (approx.)
gptkbp:services Pharmaceutical manufacturing
gptkbp:subsidiary gptkb:Ranbaxy_Laboratories_Limited
gptkbp:sustainabilityInitiatives Environmental responsibility programs
gptkbp:type Public company
gptkbp:website www.ranbaxy.com